Search Orphan Drug Designations and Approvals
-
Generic Name: | somatropin [rDNA] | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Genotropin | ||||||||||||||||
Date Designated: | 12/27/2000 | ||||||||||||||||
Orphan Designation: | Treatment of growth failure in children who were born small for gestational age. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Pharmacia and Upjohn Company 7000 Portage Road Kalamazoo, Michigan 49001 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | somatropin [rDNA] |
---|---|---|
Trade Name: | Genotropin | |
Marketing Approval Date: | 07/25/2001 | |
Approved Labeled Indication: | For long-term treatment of growth failure in children born small for gestational age who fail to manifest catch-up growth by two years of age. | |
Exclusivity End Date: | 07/25/2008 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-